Financial Gravity Asset Management, Inc. Jazz Pharmaceuticals PLC Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	SELL	$115.19 - $132.77 $575 - $663	-5 Reduced 71.43%	2 $263,000
Q1 2024 May 13, 2024	BUY	$115.19 - $132.77 $921 - $1,062	8 Added 114.29%	15 $1.83 Million
Q4 2023 Jun 26, 2024	SELL	$114.26 - $136.0 $914 - $1,088	-8 Reduced 53.33%	7 $982,000
Q3 2023 Nov 15, 2023	SELL	$122.0 - $145.31 $14,274 - $17,001	-117 Reduced 94.35%	7 $0
Q2 2023 Aug 08, 2023	SELL	$122.5 - $147.16 $2,695 - $3,237	-22 Reduced 15.07%	124 $1.54 Million
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $1,741 - $2,086	-13 Reduced 8.18%	146 $1.13 Million
Q4 2022 Feb 15, 2023	SELL	$129.72 - $159.85 $445,199 - $548,605	-3,432 Reduced 95.57%	159 $1.15 Million
Q3 2022 Nov 03, 2022	BUY	$126.59 - $161.18 $217,608 - $277,068	1,719 Added 91.83%	3,591 $2.96 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $28,650 - $35,514	221 Added 13.39%	1,872 $1.2 Million
Q4 2021 Feb 11, 2022	BUY	$119.87 - $145.67 $196,946 - $239,335	1,643 Added 20537.5%	1,651 $986,000
Q2 2021 Aug 11, 2021	SELL	$160.2 - $186.42 $3,684 - $4,287	-23 Reduced 74.19%	8 $178,000
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $2,403 - $2,776	-16 Reduced 34.04%	31 $5.05 Million
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $6,613 - $7,757	47 New	47 $7,000
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $29,469 - $37,539	-308 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$87.74 - $152.74 $18,600 - $32,380	-212 Reduced 40.77%	308 $30,000
Q4 2019 Feb 28, 2020	SELL	$117.65 - $153.73 $30,706 - $40,123	-261 Reduced 33.42%	520 $149,000
Q3 2019 Oct 15, 2019	SELL	$125.18 - $143.24 $21,906 - $25,067	-175 Reduced 18.31%	781 $100,000
Q2 2019 Jul 26, 2019	SELL	$125.55 - $144.48 $25,486 - $29,329	-203 Reduced 17.52%	956 $136,000
Q1 2019 Apr 19, 2019	BUY	$121.81 - $142.95 $5,481 - $6,432	45 Added 4.04%	1,159 $166,000
Q3 2018 Oct 31, 2018	SELL	$161.01 - $180.57 $8,855 - $9,931	-55 Reduced 4.7%	1,114 $171,000
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $14,925 - $18,684	-102 Reduced 8.03%	1,169 $206,000
Q1 2018 May 23, 2018	BUY	$135.59 - $157.16 $172,334 - $199,750	1,271 New	1,271 $192,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account